PGxAI
PGxAI is a precision medicine company that leverages generative AI and real-world evidence to optimize drug therapies. Their platform aims to deliver the right treatment, at the right dose, at the right time for every patient. PGxAI's approach integrates genetic, proteomic, transcriptomic, metabolomic, and clinical data to provide unparalleled precision. They have established strategic partnerships with leading technology and healthcare organizations such as InterSystems, Google Cloud, Microsoft, and NVIDIA, and have demonstrated clinical outcomes including a 35% reduction in adverse drug events and a 2-day shorter Length of Stay (LOS). The company serves providers, labs, CROs, payors, and patients, aiming to enhance clinical decision-making, accelerate clinical trials, and improve patient care worldwide. PGxAI is backed by top-tier VC firms and corporate partners, with a vision to set a new global standard in precision medicine.
PGxAI
PGxAI is a precision medicine company that leverages generative AI and real-world evidence to optimize drug therapies. Their platform aims to deliver the right treatment, at the right dose, at the right time for every patient. PGxAI's approach integrates genetic, proteomic, transcriptomic, metabolomic, and clinical data to provide unparalleled precision. They have established strategic partnerships with leading technology and healthcare organizations such as InterSystems, Google Cloud, Microsoft, and NVIDIA, and have demonstrated clinical outcomes including a 35% reduction in adverse drug events and a 2-day shorter Length of Stay (LOS). The company serves providers, labs, CROs, payors, and patients, aiming to enhance clinical decision-making, accelerate clinical trials, and improve patient care worldwide. PGxAI is backed by top-tier VC firms and corporate partners, with a vision to set a new global standard in precision medicine.